Inventor · disambiguated record
Hye Nan Kim
Also filed as: KIM HYE-NAN
7 granted patents·4 pending applications·11 citations·filing 2008–2017
76Inventor score
Files withKOREA RES INST OF BIOSCIENCE4PARK YOUNG-WOO2ANTIBODY AND RECEPTOR THERAPEUTICS CO LTD1KWON BYOUNG MOG1MEDPACTO INC1
Top patents by PatentIndex Score
11 records- 0182US9631020B2Anti-c-Met antibody having HGF activity and use thereofPARK YOUNG WOO·Filed 2012·Granted Apr 25, 2017·5 cites·20 claims
- 0281US9364556B2Drug conjugate comprising drug linked to human c-Met antibody, and use thereforKOREA RES INST OF BIOSCIENCE·Filed 2012·Granted Jun 14, 2016·4 cites·16 claims
- 0370US11248048B2Antibody to programmed cell death 1 (PD-1) and use thereofY BIOLOGICS INC·Filed 2017·Granted Feb 15, 2022·1 cites·12 claims
- 0459US9388223B2Myostatin inhibitor comprising extracellular water-soluble domains of DLK1 as active ingredientANTIBODY AND RECEPTOR THERAPEUTICS CO LTD·Filed 2013·Granted Jul 12, 2016·1 cites·11 claims
- 0559US2009263521A1Composition for the treatment of cancers and inhibition of metastasis containing extracts or fractions of the magnolia obovataKOREA RES INST OF BIOSCIENCE·Filed 2008·Application pending·0 cites
- 0659US2009311354A1Composition comprising extracts or fractions of magnolia obovata thunb for treating and preventing inflammation diseaseKOREA RES INST OF BIOSCIENCE·Filed 2008·Application pending·0 cites
- 0754US8183405B2Obovatol derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical composition for the prevention and treatment of cancer containing the same as an active ingredientKWON BYOUNG-MOG·Filed 2008·Granted May 22, 2012·0 cites·2 claims
- 0854US7939542B2Cinnamaldehyde derivatives having improved solubility in water, a method for preparing the same and a pharmaceutical composition comprising the sameKOREA RES INST OF BIOSCIENCE·Filed 2008·Granted May 10, 2011·0 cites·9 claims
- 0953US2010125103A1Composition for the treatment of diabetes and metabolic syndrome containing obovatol and its synthesized derivativesTG BIOTECH CO LTD·Filed 2009·Application pending·0 cites
- 1041US2014072558A1Activin Receptor Type II B Inhibitors Comprising DLK1 Extracellular Water-Soluble DomainPARK YOUNG WOO·Filed 2012·Application pending·0 cites
- 1135US10259850B2Modified DKK2 protein, nucleic acid encoding the same, preparation method thereof, and use thereofMEDPACTO INC·Filed 2016·Granted Apr 16, 2019·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Hye Nan Kim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →